References
- Harrison P. M., Hoare R. J. Metals in Biochemistry. Chapman and Hall, London 1980
- Gutteridge J.M.C., Stocks J. Caeruloplasmin: physiological and pathological perspectives. CRC Crit. Rev. Clin. Lab. Sci 1981; 14: 257–329
- Cousins R. J. Absorption, transport and hepatic metabolism of copper and zinc: special reference to metallothionein and ceruloplasmin. Physiol. Rev 1985; 65: 238–309
- Neumann P. Z., Sass-Kortsak A. The state of copper in human serum: evidence for an amino acid-bound fraction. J. Clin. Invest 1967; 46: 646–658
- Lau S. J., Sarkar B. The interaction of copper (II) and glycyl-L-histidyl-L-lysine, a growth-modulating trepeptide from plasma. Biochem. J 1981; 199: 649–656
- Berthon G., Hacht B., Blais M. J., May P. M. Copper-histidine ternary complex equilibra with glutamine, asparagine and serine. The implications for computer-simulated distributions of copper (II) in blood plasma. Inorg. Chim. Acta 1986; 125: 219–227
- Gutteridge J.M.C. Copper-phenanthroline induced site specific oxygen radical damage to DNA. Detection of loosely bound trace copper in biological fluids. Biochem. J 1984; 218: 983–985
- Gutteridge J. M.C., Winyard P.G., Blake D., Lunec R., Brailsford J. S., Halliwell B. The behaviour of caeruloplasmin in stored human extracellular fluids in relation to ferroxidase II activity, lipid peroxidation and phenanthroline-detectable copper. Biochem. J 1985; 230: 517–523
- Topham R. W., Frieden E. Identification and purification of a non-ceruloplasmin ferroxidase of human serum. J. Biol. Chem 1970; 245: 6698–6705
- Chin J. L., Calisch M.P., Topham R. W. Purification and characterization of the ferroxidase-II from rabbit (Oryctolagus cuniculus) serum. Int. J. Biochem 1978; 9: 775–783
- Topham R. W., Sung C.S.M., Morgan F. G., Prince W. D., Jones S. H. Functional significance of the copper and lipid components of human ferroxidase-II. Arch. Biochem. Biophys 1975; 167: 129–137
- Czaja M. J., Weiner F. R., Schwarzenberg S. J., Sternlieb I., Scheinberg H., Van Thiel T. H., La Russo N. F., Giambrone M. A., Kirschner R., Koschinsky M. L., MacGillivray R. T.A., Zern M. A. Molecular studies of ceruloplasmin deficiency in Wilson's disease. J. Clin. Invest 1987; 80: 1200–1204
- Brewer G. J., Hill G. M., Dick R. D., Nostrant T. T., Sams J. S., Wells J. J., Prasad A. S. Treatment of Wilson's disease with zinc: III Prevention of reaccumulation of hepatic copper. J. Lab. Clin. Med 1987; 109: 526–531
- Johnson D. A., Osaki S., Frieden E. A micromethod for the determination of ferroxidase (ceruloplasmin) in human serums. Clin. Chem 1967; 13: 142–150
- Laurie S. H., Pratt D. E. Copper-albumin: what is its functional role?. Biochem. Biophys. Res. Commun 1986; 135: 1064–1068
- McCardle H. J., Guthrie J. R., Ackland M. L., Danks D. M. Albumin has no role in the uptake of copper by human fibroblasts. J. Inorg. Biochem 1987; 31: 123–131
- Scheinberg I. H., Sternlieb I., Schilsky M., Stockert R. J. Penicillamine may detoxify copper in Wilson's disease. Lancet 1987; ii
- Scheinberg I. H., Jaffe M. E., Sternlieb I. The use of trientine in preventing the effects of interrupting penicillamine therapy in Wilson's disease. New Engl. J. Med 1987; 317: 209–213
- Trey C., Davidson L. S. The management of fulminant hepatic failure. Progress in Liver Disease, H Popper, E Schaffner. Grune and Stratton, New York 1970; 282–298